Evidence map›Paper›PMID 33467111›Full record

ArticleCells2021

Exogenous Fatty Acids Modulate ER Lipid Composition and Metabolism in Breast Cancer Cells.

Angela Maria Rizzo, Irma Colombo, Gigliola Montorfano, Stefania Zava, Paola Antonia Corsetto

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Overcharged lipid metabolism in mechanisms of antitumor byInternational journal of oncology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Expanding Roles of De Novo Lipogenesis in Breast Cancer.International journal of environmental research and public health · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angela Maria RizzoDepartment of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, 20122 Milano, Italy.ORCID 0000-0002-8582-0432
Irma ColomboDepartment of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, 20122 Milano, Italy.ORCID 0000-0002-9021-3119
Gigliola MontorfanoDepartment of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, 20122 Milano, Italy.
Stefania ZavaDepartment of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, 20122 Milano, Italy.
Paola Antonia CorsettoDepartment of Pharmacological and Biomolecular Sciences, Università degli studi di Milano, 20122 Milano, Italy.ORCID 0000-0003-3849-8548
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Lipid metabolism is a fundamental hallmark of all tumors, especially of breast cancer. Few studies describe the different lipid metabolisms and sensitivities to the microenvironment of breast cancer cell subtypes that influence the proliferation, aggressiveness, and success of therapy. This study describes the impact of lipid microenvironment on endoplasmic reticulum (ER) membrane and metabolic activity in two breast cancer cell lines with Luminal A and triple-negative breast cancer (TNBC) features. (2) Methods: We investigated the peculiar lipid phenotype of a TNBC cell line, MDA-MB-231, and a Luminal A cell line, MCF7, and their different sensitivity to exogenous fatty acids (i.e., palmitic acid (PA) and docosahexaenoic acid (DHA)). Moreover, we verified the impact of exogenous fatty acids on ER lipid composition. (3) Results: The data obtained demonstrate that MDA-MB-231 cells are more sensitive to the lipid microenvironment and that both PA and DHA are able to remodel their ER membranes with consequences on resident enzyme activity. On the contrary, MCF7 cells are less sensitive to PA, whereas they incorporate DHA, although less efficiently than MDA-MB-231 cells. (4) Conclusions: This study sustains the importance of lipid metabolism as an innovative hallmark to discriminate breast cancer subclasses and to develop personalized and innovative pharmacological strategies. The different sensitivities to the lipid environment shown by MCF7 and MDA-MB-231 cells might be related to cell malignancy and chemoresistance onset. In the future, this new approach could lead to a substantial decrease both in deleterious side effects for the patients and in the cost of entire therapeutic treatments coupled with increased therapy efficiency.

Indexed as

Fatty AcidsBreast NeoplasmsEndoplasmic ReticulumFemaleHumansIntracellular MembranesMCF-7 CellsFatty AcidscancerERfatty acidslipid metabolism

Identifiers

PMID33467111
PMCPMC7830208
OpenAlexW3125057664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.